Stocks Amgen Inc

More

  • Big pharma has to change the way it sells drugs. That's the conclusion of a new PricewaterhouseCoopers report about what the industry will look like in 2020, which calls the big pharma sales model "increasingly ineffective."

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Is there a pipeline from the C-suite of McDonald's to the ivory towers of biopharma? At least one "Pharma's Market" reader from overseas thinks so.

  • Lance Armstrong

    The "Amgen Tour of California" is getting a lot more publicity than usual because superstar cyclists Lance Armstrong and Floyd Landis are trying to make comebacks in the race.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • If you’re looking for trading action look no farther than healthcare. There’s something happening in almost every corner of this sector.

  • With all that’s happening in Washington and on Wall Street, investors are desperate to discover where the momentum will continue building.

  • graphic_word_ofthe_street.jpg

    The Dow rallied for a second day on Friday on hopes Washington's stimulus package and a bank rescue plan will bolster the ailing economy.

  • graphic_word_ofthe_street.jpg

    Stocks ended higher Tuesday, snapping a three-day losing streak, after strong earnings from Merck and a better-than-expected housing report lifted sentiment on the Street.

  • The health care sector today just went positive for 2009, making it the only major industry group to currently be in the green for this young year.

  • graphic_word_ofthe_street.jpg

    The Dow and S&P 500 fell on Monday as uncertainty about the Obama administration's plan to stem bank losses dragged down financial shares.

  • Call options are heating up in Amgen, which is up slightly Monday in a sluggish market. As AMGN trades at about $55.20 the Febuary 57.5 and 60 calls are drawing a few nibbles, but most of today's action involves the Febuary 65 calls. What's it mean?

  • graphic_fast_money.jpg

    Thomas writes, "Is it time to short the XLF? " Also Yog asks, "what are the traders thoughts on Amgen after their earnings report?"

  • graphic_word_ofthe_street.jpg

    Stocks climbed on Tuesday, with the S&P 500 and the Nasdaq up for a third straight day after encouraging news on the earnings front...

  • Investors can’t help but wonder what’s the best way to play Pharma after Pfizer said it would buy rival Wyeth for $60 billion, a 20% premium!

  • webxtra_thumb.jpg

    In this Web Extra, the traders reveal how they're gaming earnings from McDonald's, Amgen, Caterpillar, Starbucks as well as the Fed Meeting and much more!

  • johnson_johnson2_logo.jpg

    Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.

  • Some call it the Super Bowl of healthcare. We’re talking about the JP Morgan Healthcare Conference kicking off Monday and it could move stocks.

  • Following are the year’s biggest winners and losers. Find out why shares of McDonald’s and Gilead Sciences popped while General Motors and Citigroup dropped.